In a nutshell This study investigated the benefits of repeated cytoreductive surgery (CRS) and hyperthermic peritoneal chemotherapy (HIPEC) in patients with advanced colorectal cancer. Researchers suggested that repeated treatment improves the survival of patients with advanced colorectal cancer, without an increase in side effects. Some background...
Read MoreTreatment(s) already received-HIPEC Posts on Medivizor
Comparing the safety of surgery options for patients with peritoneal metastasis
In a nutshell This study investigated the safety of hyperthermic intraperitoneal chemotherapy (HIPEC) and surgery in colon cancer patients with peritoneal metastasis (PM). Researchers reported that HIPEC and surgery was associated with an increased risk of complications. Some background When colon cancer spreads to the abdominal lining (known as...
Read MoreEvaluating the risks and benefits of treatment for abdominal cancer spread
In a nutshell The present study evaluated the long-term quality of life (QOL) for patients with peritoneal carcinomatosis (PC) who had cytoreductive surgery (CRS) and HIPEC (hyperthermic perioperative chemotherapy). Main findings: patients who survived the procedure regained their baseline (pre-operative) QOL within 6-12 months after...
Read MoreTreating tumors of the appendix to reduce the risk of spread to the abdominal cavity
In a nutshell The present study classified tumors of the appendix and reviewed treatments that aim to prevent cancer spread to the abdominal cavity. Some background Pseudomyxoma peritonei (PMP) is a rare condition caused by the production of too much mucin (a protein that is secreted in mucus). PMP affects women more than men and symptoms...
Read More